prednisolone has been researched along with Adenoma, Bile Duct in 2 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Adenoma, Bile Duct: A benign tumor of the intrahepatic bile ducts.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
PLENGVANIT, U | 1 |
VIRANUVATTI, V | 2 |
Umsawasdi, T | 1 |
Chainuvati, T | 1 |
Hitanant, S | 1 |
Nilprabhassorn, P | 1 |
2 other studies available for prednisolone and Adenoma, Bile Duct
Article | Year |
---|---|
TREATMENT OF PRIMARY CARCINOMA OF THE LIVER WITH NITROGEN MUSTARD AND PREDNISOLONE: REORT OF 51 CASES.
Topics: Adenoma, Bile Duct; Alkaline Phosphatase; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma; | 1964 |
Combination chemotherapy with 5--fluorouracil, amethopterin (methotrexate) and prednisolone (FAP protocol) in the therapy of cholangiocarcinoma.
Topics: Adenoma, Bile Duct; Drug Therapy, Combination; Fluorouracil; Humans; Liver Neoplasms; Male; Methotre | 1976 |